Jeremy Steven Davis's most recent trade in Standard BioTools Inc was a trade of 20,833 Restricted Stock Units done . Disclosure was reported to the exchange on Feb. 21, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Standard BioTools Inc | Jeremy Steven Davis | SVP Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 20,833 | 229,167 | - | - | Restricted Stock Units | |
| Standard BioTools Inc | Jeremy Steven Davis | SVP Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2023 | 20,833 | 20,833 (0%) | 0% | 0 | Common Stock | |
| Standard BioTools Inc | Jeremy Steven Davis | SVP Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.03 per share. | 21 Feb 2023 | 6,176 | 14,657 (0%) | 0% | 2.0 | 12,537 | Common Stock |
| Standard BioTools Inc | Jeremy Steven Davis | SVP Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2022 | 250,000 | 250,000 | - | - | Restricted Stock Units |